Concepedia

Publication | Closed Access

Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth

DOI

119

Citations

18

References

2013

Year

Muralimohan Yepuru, Zhongzhi Wu, Anand Kulkarni, Feng Yin, Christina M. Barrett, Ju-Hyun Kim, Mitchell S. Steiner, Duane D. Miller, James T. Dalton, Ramesh Narayanan
Clinical Cancer Research

Abstract

AKR1C3 is a novel AR-selective enzymatic coactivator and may represent the first of more than 200 known nuclear hormone receptor coactivators that can be pharmacologically targeted.

References

YearCitations

Page 1